Ursolic Acid Derivative UAOS-Na Treats Experimental Autoimmune Encephalomyelitis by Immunoregulation and Protecting Myelin

Overview

Journal Front Neurol

Specialty Neurology

Date 2023 Dec 18

PMID 38107649

Authors

Maolin Wang

Chenming Gu

Yifu Yang

Liang Chen

Kaixian Chen

Jun Du

Huali Wu

Yiming Li

Affiliations

Soon will be listed here.

Abstract

Introduction: Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS). Ursolic acid (UA) can be used in the MS treatment with anti-inflammatory and neuroprotective activities. However, UA is insoluble in water, which may affect its medication effectiveness. In our previous study, UAOS-Na, a water-soluble derivative of UA was obtained. In this study, we evaluated the pharmacological effects and explored its underlying mechanism of UAOS-Na on experimental autoimmune encephalomyelitis (EAE).

Methods: Firstly, the pharmacodynamics of UAOS-Na was investigated in EAE and Cuprizone-induced mice. And then the possible mechanisms were investigated by TMT proteomics and verified by in vitro and in vivo experiments.

Results: UAOS-Na (30 mg/kg/d) delayed the onset time of EAE from 11.78 days post immunization (dpi) to 14.33 dpi, reduced the incidence from 90.0% to 42.9%. UAOS-Na (60 mg/kg/d) reduced the serum levels of IFN-γ, IL-17A, TNF-α and IL-6, reduced the mononuclear cell infiltration of spinal cord, and inhibited the overexpression of key transcription factors T-bet and ROR-γt of EAE mouse spinal cord. In addition, UAOS-Na attenuated demyelination and astrogliosis in the CNS of EAE and cuprizone-induced mice. Mechanistically, proteomics showed that 96 differential expression proteins (DEPs) were enriched and 94 were upregulated in EAE mice compared with normal group. After UAOS-Na treatment, 16 DEPs were enriched and 15 were downregulated, and these DEPs were markedly enriched in antigen processing and presentation (APP) signaling pathway. Moreover, UAOS-Na downregulated the protein levels of Tapbp and H2-T23 in MHC-I antigen presentation pathway and reduced the proliferation of splenic CD8 T cells, thereby inhibiting the CNS infiltration of CD8 T cells.

Conclusion: Our findings demonstrated that UAOS-Na has both myelin protective and anti-inflammatory effects. And it could reduce the inflammation of MS by downregulating the expression of Tapbp and H2-T23 in the MHC-I antigen presentation pathway.

References

Liao Q, Yang W, Jia Y, Chen X, Gao Q, Bi K . LC-MS determination and pharmacokinetic studies of ursolic acid in rat plasma after administration of the traditional chinese medicinal preparation Lu-Ying extract. Yakugaku Zasshi. 2005; 125(6):509-15. DOI: 10.1248/yakushi.125.509. View

Thompson A, Baranzini S, Geurts J, Hemmer B, Ciccarelli O . Multiple sclerosis. Lancet. 2018; 391(10130):1622-1636. DOI: 10.1016/S0140-6736(18)30481-1. View

Tan J, Liu H, Huang M, Li N, Tang S, Meng J . Small molecules targeting RORγt inhibit autoimmune disease by suppressing Th17 cell differentiation. Cell Death Dis. 2020; 11(8):697. PMC: 7443190. DOI: 10.1038/s41419-020-02891-2. View

Domon B, Aebersold R . Mass spectrometry and protein analysis. Science. 2006; 312(5771):212-7. DOI: 10.1126/science.1124619. View

Blakemore W . Observations on oligodendrocyte degeneration, the resolution of status spongiosus and remyelination in cuprizone intoxication in mice. J Neurocytol. 1972; 1(4):413-26. DOI: 10.1007/BF01102943. View

Greter M, Lelios I, Croxford A . Microglia Versus Myeloid Cell Nomenclature during Brain Inflammation. Front Immunol. 2015; 6:249. PMC: 4443742. DOI: 10.3389/fimmu.2015.00249. View

Dulamea A . The contribution of oligodendrocytes and oligodendrocyte progenitor cells to central nervous system repair in multiple sclerosis: perspectives for remyelination therapeutic strategies. Neural Regen Res. 2018; 12(12):1939-1944. PMC: 5784335. DOI: 10.4103/1673-5374.221146. View

Havrdova E, Arnold D, Cohen J, Hartung H, Fox E, Giovannoni G . Alemtuzumab CARE-MS I 5-year follow-up: Durable efficacy in the absence of continuous MS therapy. Neurology. 2017; 89(11):1107-1116. PMC: 5595278. DOI: 10.1212/WNL.0000000000004313. View

Salou M, Nicol B, Garcia A, Laplaud D . Involvement of CD8(+) T Cells in Multiple Sclerosis. Front Immunol. 2015; 6:604. PMC: 4659893. DOI: 10.3389/fimmu.2015.00604. View

10.

Hartung D . Economics and Cost-Effectiveness of Multiple Sclerosis Therapies in the USA. Neurotherapeutics. 2017; 14(4):1018-1026. PMC: 5722771. DOI: 10.1007/s13311-017-0566-3. View

11.

Williams A, Peh C, Purcell A, McCluskey J, Elliott T . Optimization of the MHC class I peptide cargo is dependent on tapasin. Immunity. 2002; 16(4):509-20. DOI: 10.1016/s1074-7613(02)00304-7. View

12.

Thomas C, Tampe R . MHC I chaperone complexes shaping immunity. Curr Opin Immunol. 2019; 58:9-15. DOI: 10.1016/j.coi.2019.01.001. View

13.

Weaver A, Goncalves da Silva A, Nuttall R, Edwards D, Shapiro S, Rivest S . An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1/Th2 polarization. FASEB J. 2005; 19(12):1668-70. DOI: 10.1096/fj.04-2030fje. View

14.

Garbi N, Tiwari N, Momburg F, Hammerling G . A major role for tapasin as a stabilizer of the TAP peptide transporter and consequences for MHC class I expression. Eur J Immunol. 2003; 33(1):264-73. DOI: 10.1002/immu.200390029. View

15.

Vora P, Pillai P, Mustapha J, Kowal C, Shaffer S, Bose R . CXCL1 regulation of oligodendrocyte progenitor cell migration is independent of calcium signaling. Exp Neurol. 2012; 236(2):259-67. DOI: 10.1016/j.expneurol.2012.04.012. View

16.

Grace P, Loram L, Christianson J, Strand K, Flyer-Adams J, Penzkover K . Behavioral assessment of neuropathic pain, fatigue, and anxiety in experimental autoimmune encephalomyelitis (EAE) and attenuation by interleukin-10 gene therapy. Brain Behav Immun. 2016; 59:49-54. PMC: 5108696. DOI: 10.1016/j.bbi.2016.05.012. View

17.

Liu B, Liu Y, Yang G, Xu Z, Chen J . Ursolic acid induces neural regeneration after sciatic nerve injury. Neural Regen Res. 2014; 8(27):2510-9. PMC: 4145935. DOI: 10.3969/j.issn.1673-5374.2013.27.002. View

18.

Honarvar F, Hojati V, Zare L, Bakhtiari N, Javan M . Ursolic Acid Enhances Myelin Repair in Adult Mice Brains and Stimulates Exhausted Oligodendrocyte Progenitors to Remyelinate. J Mol Neurosci. 2022; 72(10):2081-2093. DOI: 10.1007/s12031-022-02059-x. View

19.

Chen H, Gao Y, Wang A, Zhou X, Zheng Y, Zhou J . Evolution in medicinal chemistry of ursolic acid derivatives as anticancer agents. Eur J Med Chem. 2015; 92:648-55. PMC: 4336574. DOI: 10.1016/j.ejmech.2015.01.031. View

20.

Ikeda Y, Murakami A, Ohigashi H . Ursolic acid: an anti- and pro-inflammatory triterpenoid. Mol Nutr Food Res. 2008; 52(1):26-42. DOI: 10.1002/mnfr.200700389. View